Trial intelligence / Profile preview

Aldosterone antagonists in adults with systemic right ventricle after atrial switch

2007-002605-53Phase 4Active

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Apr 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of eplerenone in transposition of the great arteries (TGA) and Systemic right ventricle (SRV) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Right ventricular myocardial mass index. Started Apr 2008; status: active.

02

Drugs

eplerenone
03

Conditions

transposition of the great arteries (TGA)Systemic right ventricle (SRV)

Beyond the preview

Go deeper on 2007-002605-53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002605-53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call